Table 2 Clinical evidence GLP-1 receptor agonists, reported adverse effects and taste perception
Asia-Pacific (including Japan) - Strongest growth region supported by rising diabetic population, expanding healthcare access, increasing awareness, and large-scale pharmaceutical manufacturing in China, India, and Southeast Asia, along with Japan's advanced diabetes care ecosystem
The biggest drug category in a generation may need a second drug to complete the prescription
10.1016/j.foodchem.2022.132531 131 ShenY.YaoY.LiH.ZhangQ.WangC.HuL.et al (2025)
Weight management/metabolic effects: GLP-1 RAs may also support weight management in adults with type 2 diabetes who are overweight or obese, providing an added metabolic advantage alongside their primary glycaemic and cardioprotective effects
What precautions should be taken before medical procedures for patients on GLP-1 medications